Stiripentol for dravet syndrome: is it worth it?
- PMID: 24526870
- PMCID: PMC3913306
- DOI: 10.5698/1535-7597-14.1.22
Stiripentol for dravet syndrome: is it worth it?
Similar articles
-
Stiripentol: A Novel Antiseizure Medication for the Management of Dravet Syndrome.Ann Pharmacother. 2019 Nov;53(11):1136-1144. doi: 10.1177/1060028019856008. Epub 2019 Jun 6. Ann Pharmacother. 2019. PMID: 31167540 Clinical Trial.
-
Stiripentol in Dravet syndrome: results of a retrospective U.S. study.Epilepsia. 2013 Sep;54(9):1595-604. doi: 10.1111/epi.12303. Epub 2013 Jul 12. Epilepsia. 2013. PMID: 23848835
-
Efficacy of Stiripentol and the Clinical Outcome in Dravet Syndrome.J Child Neurol. 2019 Jan;34(1):33-37. doi: 10.1177/0883073818811538. Epub 2018 Oct 26. J Child Neurol. 2019. PMID: 30362398
-
Stiripentol for the treatment of seizures in Dravet syndrome.Expert Rev Clin Pharmacol. 2019 May;12(5):379-388. doi: 10.1080/17512433.2019.1605904. Epub 2019 Apr 24. Expert Rev Clin Pharmacol. 2019. PMID: 31017478 Review.
-
Current therapeutic procedures in Dravet syndrome.Dev Med Child Neurol. 2011 Apr;53 Suppl 2:16-8. doi: 10.1111/j.1469-8749.2011.03967.x. Dev Med Child Neurol. 2011. PMID: 21504427 Review.
References
-
- Scheffer IE. Diagnosis and long-term course of Dravet syndrome. Eur J Paediatr Neurol. 2012;16(suppl 1):S5–S8. - PubMed
-
- Chiron C, Dulac O. The pharmacologic treatment of Dravet syndrome. Epilepsia. 2011;52(suppl 2):72–75. - PubMed
-
- Laux L, Blackford R. The ketogenic diet in Dravet syndrome. J Child Neurol. 2013;8:1041–1044. - PubMed
-
- Levy RH, Lin HS, Blehaut HM, Tor JA. Pharmacokinetics of stiripentol in normal man: Evidence of nonlinearity. J Clin Pharmacol. 1983;23:523–533. - PubMed
-
- Chiron C, Marchand MC, Tran A, Rey E, d'Athis P, Vincent J, Dulac O, Pons G. Stiripentol in severe myoclonic epilepsy in infancy: A randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet. 2000;356:1638–1642. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
